Recommendations for live viral and bacterial vaccines in immunodeficient patients and their close contacts. Read more about Recommendations for live viral and bacterial vaccines in immunodeficient patients and their close contacts.
B-cell development and functions and therapeutic options in adenosine deaminase-deficient patients. Read more about B-cell development and functions and therapeutic options in adenosine deaminase-deficient patients.
Survey on retransplantation criteria for patients with severe combined immunodeficiency. Read more about Survey on retransplantation criteria for patients with severe combined immunodeficiency.
A systematic analysis of recombination activity and genotype-phenotype correlation in human recombination-activating gene 1 deficiency. Read more about A systematic analysis of recombination activity and genotype-phenotype correlation in human recombination-activating gene 1 deficiency.
Establishing diagnostic criteria for severe combined immunodeficiency disease (SCID), leaky SCID, and Omenn syndrome: the Primary Immune Deficiency Treatment Consortium experience. Read more about Establishing diagnostic criteria for severe combined immunodeficiency disease (SCID), leaky SCID, and Omenn syndrome: the Primary Immune Deficiency Treatment Consortium experience.
Primary Immune Deficiency Treatment Consortium (PIDTC) report. Read more about Primary Immune Deficiency Treatment Consortium (PIDTC) report.
Predictors of response to tiotropium versus salmeterol in asthmatic adults. Read more about Predictors of response to tiotropium versus salmeterol in asthmatic adults.
Tmem79/Matt is the matted mouse gene and is a predisposing gene for atopic dermatitis in human subjects. Read more about Tmem79/Matt is the matted mouse gene and is a predisposing gene for atopic dermatitis in human subjects.
A genome-wide association study of bronchodilator response in Latinos implicates rare variants. Read more about A genome-wide association study of bronchodilator response in Latinos implicates rare variants.
Newborn screening for severe combined immunodeficiency and T-cell lymphopenia in California: results of the first 2 years. Read more about Newborn screening for severe combined immunodeficiency and T-cell lymphopenia in California: results of the first 2 years.
